Suppr超能文献

结直肠癌中克罗恩样淋巴样反应评估标准的比较验证

Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.

作者信息

Kim Jung Ho, Kim Kyung-Ju, Bae Jeong Mo, Rhee Ye-Young, Cho Nam-Yun, Lee Hye Seung, Kang Gyeong Hoon

机构信息

Department of Pathology, SMG-SNU Boramae Medical Centre, Seoul, Korea.

Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Clin Pathol. 2015 Jan;68(1):22-8. doi: 10.1136/jclinpath-2014-202603. Epub 2014 Oct 16.

Abstract

AIMS

Crohn-like lymphoid reaction (CLR) in colorectal carcinoma (CRC) is associated with a favourable prognosis and microsatellite instability-high (MSI-H) status. However, there is a lack of consensus on optimal criteria for CLR assessment. The aim of this study was to comparatively validate traditional and novel assessment criteria for CLR.

METHODS

CLR status in 212 MSI-H CRCs was assessed independently by two pathologists using three different criteria: (1) traditional semiquantitative criteria (Graham-Appelman criteria), (2) the largest lymphoid aggregate (LA) size-based criteria (Ueno criteria) and (3) LA density-based criteria (Väyrynen-Mäkinen criteria).

RESULTS

Among the three criteria, the Väyrynen-Mäkinen criteria-based CLR assessment showed the best interobserver agreement (κ value, 0.71; intraclass correlation coefficient, 0.76). Pathologically, intense CLR (grade 2) by Graham-Appelman criteria, active CLR (largest LA size ≥1 mm) by Ueno criteria and high-density CLR (≥0.38 LAs/mm) by Väyrynen-Mäkinen criteria significantly correlated with an early cancer stage (stage I/II). In Kaplan-Meier analysis, both CLR statuses determined by Ueno criteria and Väyrynen-Mäkinen criteria were associated with significant differences in disease-free survival in MSI-H CRC patients (p=0.005 and p=0.001, respectively). In multivariable analysis, both active CLR and high-density CLR proved to be independent favourable prognostic factors in MSI-H CRC (HR, 0.47; 95% CI 0.24 to 0.9 for active CLR and HR, 0.5; 95% CI 0.28 to 0.89 for high-density CLR).

CONCLUSIONS

Our study confirms that the two recently suggested criteria (Ueno criteria and Väyrynen-Mäkinen criteria) for CLR assessment are fairly reproducible methods and can serve as superior prognosticators in CRC.

摘要

目的

结直肠癌(CRC)中的克罗恩样淋巴反应(CLR)与良好的预后及微卫星高度不稳定(MSI-H)状态相关。然而,关于CLR评估的最佳标准尚未达成共识。本研究的目的是对CLR的传统评估标准和新评估标准进行比较验证。

方法

两名病理学家使用三种不同标准独立评估212例MSI-H CRC中的CLR状态:(1)传统半定量标准(Graham-Appelman标准),(2)基于最大淋巴滤泡(LA)大小的标准(Ueno标准),以及(3)基于LA密度的标准(Väyrynen-Mäkinen标准)。

结果

在这三种标准中,基于Väyrynen-Mäkinen标准的CLR评估显示出最佳的观察者间一致性(κ值为0.71;组内相关系数为0.76)。在病理方面,根据Graham-Appelman标准的强烈CLR(2级)、根据Ueno标准的活跃CLR(最大LA大小≥1mm)以及根据Väyrynen-Mäkinen标准的高密度CLR(≥0.38个LA/mm)均与早期癌症阶段(I/II期)显著相关。在Kaplan-Meier分析中,由Ueno标准和Väyrynen-Mäkinen标准确定的CLR状态均与MSI-H CRC患者的无病生存期存在显著差异(p分别为0.005和0.001)。在多变量分析中,活跃CLR和高密度CLR均被证明是MSI-H CRC的独立有利预后因素(活跃CLR的HR为0.47;95%CI为0.24至0.9;高密度CLR的HR为0.5;95%CI为0.28至0.89)。

结论

我们的研究证实,最近提出的两种CLR评估标准(Ueno标准和Väyrynen-Mäkinen标准)是相当可重复的方法,并且可作为CRC中更好的预后指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验